BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20677146)

  • 1. [Research progress in roles of microRNA in polyglutamine diseases].
    Shi YT; Jiang H; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):406-9. PubMed ID: 20677146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MicroRNAs and polyglutamine diseases].
    Zhang L; Jiang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):683-6. PubMed ID: 24327147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The advances in research on phosphorylation of polyglutamine disease].
    Zhou YF; Jiang H; Tang JG; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.
    Bauer PO; Nukina N
    J Neurochem; 2009 Sep; 110(6):1737-65. PubMed ID: 19650870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular biology of polyglutamine diseases].
    Owecki M; Kozubski W
    Postepy Hig Med Dosw; 2002; 56(6):779-88. PubMed ID: 12661407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyglutamine diseases and molecular chaperones.
    Kimura Y; Kakizuka A
    IUBMB Life; 2003 Jun; 55(6):337-45. PubMed ID: 12938736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in understanding of clinical presentations and molecular mechanisms of triplet repeat diseases].
    Tsuji S
    Nihon Rinsho; 1999 Apr; 57(4):778-86. PubMed ID: 10222765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions.
    Bates GP; Davies SW
    Mol Med Today; 1997 Nov; 3(11):508-15. PubMed ID: 9430787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic opportunities in polyglutamine disease.
    Hughes RE; Olson JM
    Nat Med; 2001 Apr; 7(4):419-23. PubMed ID: 11283667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical pathology due to trinucleotide repeats].
    Arenas-Aranda D; Peñaloza R; Salamanca-Gómez F
    Gac Med Mex; 1999; 135(1):53-65. PubMed ID: 10204311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration.
    Higashiyama H; Hirose F; Yamaguchi M; Inoue YH; Fujikake N; Matsukage A; Kakizuka A
    Cell Death Differ; 2002 Mar; 9(3):264-73. PubMed ID: 11859409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine disease and neuronal cell death.
    Paulson HL; Bonini NM; Roth KA
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):12957-8. PubMed ID: 11058149
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic strategies for the polyglutamine diseases].
    Nagai Y; Popiel HA; Fujikake N; Toda T
    Brain Nerve; 2007 Apr; 59(4):393-404. PubMed ID: 17447526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trinucleotide repeats and neurodegenerative disease.
    Everett CM; Wood NW
    Brain; 2004 Nov; 127(Pt 11):2385-405. PubMed ID: 15329351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studying polyglutamine diseases in Drosophila.
    Xu Z; Tito AJ; Rui YN; Zhang S
    Exp Neurol; 2015 Dec; 274(Pt A):25-41. PubMed ID: 26257024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program.
    Abou-Sleymane G; Chalmel F; Helmlinger D; Lardenois A; Thibault C; Weber C; Mérienne K; Mandel JL; Poch O; Devys D; Trottier Y
    Hum Mol Genet; 2006 Mar; 15(5):691-703. PubMed ID: 16434483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-selective suppression of mutant genes in polyglutamine diseases.
    Liu CR; Cheng TH
    J Neurogenet; 2015; 29(2-3):41-9. PubMed ID: 26174158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of neurodegeneration in polyglutamine diseases].
    Tsuji S
    Rinsho Shinkeigaku; 2003 Nov; 43(11):901-2. PubMed ID: 15152498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA pathways modulate polyglutamine-induced neurodegeneration.
    Bilen J; Liu N; Burnett BG; Pittman RN; Bonini NM
    Mol Cell; 2006 Oct; 24(1):157-63. PubMed ID: 17018300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways.
    Gunawardena S; Goldstein LS
    Arch Neurol; 2005 Jan; 62(1):46-51. PubMed ID: 15642849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.